PCN184 - COST-EFFECTIVENESS OF NIVOLUMAB PLUS IPILIMUMAB IN ADVANCED MELANOMA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.267
https://www.valueinhealthjournal.com/article/S1098-3015(18)33567-8/fulltext
Title :
PCN184 - COST-EFFECTIVENESS OF NIVOLUMAB PLUS IPILIMUMAB IN ADVANCED MELANOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33567-8&doi=10.1016/j.jval.2018.09.267
First page :
Section Title :
Open access? :
No
Section Order :
2010